History
History
“A long journey of continuous challenges !”
We introduce our footprints of constant endeavors for growth
We introduce our footprints of constant endeavors for growth
-
- 2019
- Total 137 products are being marketed in domestic and overseas market.
-
- 2018
- K-GMP was accredited by MFDS (Ministry of Food and Drug Safety), Korea for ‘Softgel – Pharmaceutical’ production line in the Building 4.
- Marketing Authorization was granted in U.K and Ireland for the 1st Softgel product. ‘Ibuprofen 200 mg’.
-
- 2016
- EU-GMP was accredited by MHRA(Medicines & Healthcare products RegulatoryAgency), U.K. for ‘Softgel – Pharmaceutical’ production line in the Building 4.
-
- 2013
- A building (Building 4) was constructed for ‘Softgel – Pharmaceutical’ production.
-
- 2012
- WHO-GMP was accredited by DAV (Drug Administration of Vietnam) for ‘Cephalosporin Antibiotics’ production line in the Building 3.
-
- 2010
- A building (Building 3) was constructed for ‘Cephalosporin Antibiotics’ production.
-
- 2009
- Food Hygiene & Safety was certified by MOH (Ministry of Health), Vietnam for ‘Softgel – Dietary supplement’ production line in the Building 2.
-
- 2008
- A building (Building 2) was constructed for ‘Softgel – Dietary supplement’ production.
-
- 2006
- WHO-GMP was accredited by DAV (Drug Administration of Vietnam) for ‘Softgel – Pharmaceutical’ and ’Cream & Ointment’ production lines in the Building 1.
-
- 2005
- A building (Building 1) was constructed for ‘Softgel – Pharmaceutical’ and ’Cream & Ointment’ production.
-
- 2004
- PHIL Inter Pharma was established.